Results 81 to 90 of about 11,476,807 (204)

A Severe Case of Anaplastic Large Cell Lymphoma in a Previously Healthy Woman: Diagnostic and Therapeutic Challenges

open access: yesPrague Medical Report, 2020
Anaplastic large cell lymphomas are an aggressive subtype of peripheral T-cell lymphomas that can manifest with a variety of symptoms. Our case highlights the importance of prompt tissue sampling, especially if an associated hemophagocytic ...
Petya Angelova   +7 more
doaj   +1 more source

Anaplastic large cell lymphoma. Sem. Diagn. Pathol

open access: yes, 2011
The concept of anaplastic large-cell lymphoma (ALCL) has changed over the years because of a stream of new information and novel understanding regarding the cell of origin, biology, genetics, and clinical features of these neoplasms. This new information
M. Chilosi   +34 more
core   +1 more source

Comprehensive Genomic Profiling Beyond Driver Testing in Non‐Squamous Non‐Small Cell Lung Cancer With Known Drivers

open access: yesCancer Science, EarlyView.
Figure 6 Comprehensive genomic profiling identified additional actionable alterations in a substantial proportion of patients with non‐squamous NSCLC despite previously identified driver alterations, with some findings leading to subsequent matched targeted therapies.
Yoshihiro Masui   +15 more
wiley   +1 more source

Anaplastic large T cell lymphoma presenting in the parotid gland: a diagnostic challenge

open access: yesThe Egyptian Journal of Otolaryngology
Background Non-Hodgkin lymphomas are a group of hematological malignancies that result from the uncontrolled proliferation of lymphoid cells. These malignancies are classified into different types based on histological structure and tumor cell type. This
Karima Bouali   +5 more
doaj   +1 more source

PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA

open access: yes, 2010
Anaplastic large cell lymphoma (ALCL) is characterized by proliferation of anaplastic large CD 30+ T-cell lymphoid cells with abundant cytoplasm. Primary cutaneous ALCL is a rare form of ALCL, usually seen in elderly patients. In this report, the authors
ORHAN, DİCLEHAN   +11 more
core   +1 more source

The different face of skin‐rash induced by brentuximab vedotin

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Brentuximab vedotin (BV) is a targeted therapy for CD30‐expressing lymphomas, including Hodgkin lymphoma (HL) and cutaneous T‐cell lymphoma (CTCL). While peripheral neuropathy is the most common adverse event, BV‐induced skin rashes are less frequent and not well characterized.
Alessandro Pileri   +11 more
wiley   +1 more source

Leukemic phase of anaplastic lymphoma kinase positive, anaplastic large cell lymphoma

open access: yesIndian Journal of Pathology and Microbiology, 2011
Anaplastic large cell lymphoma (ALCL) is a distinct type of CD30+ T/null-cell non-Hodgkin′s lymphoma that frequently involves nodal and extranodal sites.
Vijaya S Gadage   +8 more
doaj   +1 more source

Poorly differentiated lung adenocarcinomas with concurrent ALK and CD30 expression: a diagnostic pitfall mimicking ALK‐positive anaplastic large‐cell lymphoma

open access: yesHistopathology, EarlyView.
Poorly differentiated lung adenocarcinomas with concurrent anaplastic lymphoma kinase (ALK) and CD30 expression closely mimic ALK‐positive anaplastic large‐cell lymphoma, creating a significant diagnostic pitfall. Accurate classification requires comprehensive integration of clinical, radiologic, morphologic, immunophenotypic and molecular findings ...
Jietian Jin   +6 more
wiley   +1 more source

Systemic ALK-positive anaplastic large cell lymphoma involving implant site: a fortuitous association

open access: yesAutopsy and Case Reports, 2021
Anaplastic lymphoma kinase (ALK) positive, anaplastic large cell lymphoma involving the non-mammary implant is an extremely rare presentation.
Mayur Parkhi   +4 more
doaj  

Large cell anaplastic lypmhoma versus Hodgkin's disease – difficulties in the diagnosis [PDF]

open access: yes, 1998
During the last 5 years in the Polish Children's Leukemia/Lymphoma Study Group (7 centers) 241 children with Hodgkin's Disease and 14 children with Large Cell Anaplastic Lymphoma were treated.In 5 of them we had problems with differential diagnosis ...
Kaczmarek-Kanold, M.; Polish Children's Leukemia/Lymphoma Study Group Poznań, Wrocław, Warszawa   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy